AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...

The technology’s potential to transform trials will need to be balanced with the challenge of instilling trust in ...

Discover how digital innovation in clinical trial technology—eClinical platforms, remote data capture, and decentralized ...

AstraZeneca is the latest pharma company enlisting the services of Chinese biotechs, signing a deal worth up to $5.2bn with ...

Scientists from the A*STAR Genome Institute of Singapore (A*STAR GIS) have developed a new artificial intelligence (AI)-based ...

AI guidance for clinicians aimed at reducing the spread of Clostridioides difficile—a bacteria that can be deadly for sick ...

A team of researchers from Keio University School of Medicine, Kyoto Prefectural University of Medicine, and Teikyo ...

The announcement builds on AZ's announcement earlier this year that it will invest $2.5 billion in an R&D facility in China, ...

Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...

Parshv Gala's AI-powered AllayCare app is revolutionizing mental health diagnosis, enabling early detection, reducing ...

Databricks introduces new tools for developing and deploying data pipelines and AI agents.

Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for b ...